Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
CN Stock MarketDetailed Quotes
Shanghai Rendu Biotechnology (688193)
- 60.62
- -1.05-1.70%
Market Closed Apr 30 15:00 CST
2.43BMarket Cap175.20P/E (TTM)
63.56High60.44Low1.11MlotVolume62.10Open61.67Prev Close68.41MTurnover2.76%Turnover Ratio240.56P/E (Static)40.07MShares63.5652wk High2.64P/B2.43BFloat Cap36.4652wk Low74.00Limit Up40.07MShs Float71.33Historical High49.34Limit Down5.06%Range %21.96Historical Low0.25Dividend TTM61.90Avg Price445.10KlotAsk0.41%Div Yield TTM1Lot Size604.27KlotBid
Shanghai Rendu Biotechnology (688193) Cash Flow
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 2.96%42.7M | 0.74%202.64M | -4.96%136.59M | -8.25%83.94M | -19.88%41.47M | 1.22%201.16M | -7.51%143.72M | -15.53%91.49M | -20.80%51.76M | -23.71%198.73M |
| Refunds of taxes and levies | ---- | ---- | 51.34%4.86K | 51.34%4.86K | 100.00%4.86K | ---- | 54.50%3.21K | 54.50%3.21K | --2.43K | -99.33%2.86K |
| Cash received relating to other operating activities | -71.81%186.15K | -52.89%4.64M | -65.19%3.25M | -66.11%2.49M | -83.21%660.34K | -28.53%9.86M | 19.50%9.33M | 50.33%7.35M | 109.60%3.93M | -7.58%13.79M |
| Adjustment items of operating cash inflws | ---0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from operating activities | 1.78%42.88M | -1.77%207.29M | -8.63%139.84M | -12.55%86.44M | -24.35%42.13M | -0.71%211.01M | -6.22%153.05M | -12.69%98.84M | -17.16%55.69M | -22.96%212.52M |
| Goods services cash paid | 98.67%10.81M | 24.17%26.75M | 11.18%19.16M | -5.67%10.09M | -9.65%5.44M | 16.28%21.55M | -57.49%17.23M | -65.48%10.69M | -75.49%6.02M | -79.47%18.53M |
| Staff behalf paid | -26.78%17.86M | -7.94%76.7M | -8.42%58.8M | -4.75%42.36M | -3.39%24.4M | -8.67%83.31M | -10.05%64.21M | -12.22%44.47M | -15.21%25.25M | -8.97%91.23M |
| All taxes paid | 561.68%6.91M | 157.18%17.74M | 112.65%11.42M | 60.45%6.24M | -36.56%1.04M | -6.15%6.9M | 19.36%5.37M | -11.50%3.89M | -12.82%1.65M | -61.87%7.35M |
| Cash paid relating to other operating activities | 23.64%17.43M | -14.93%63.7M | -10.00%44.69M | -1.83%28.79M | -3.71%14.1M | -4.29%74.87M | -15.53%49.66M | -28.67%29.33M | -14.92%14.64M | 11.47%78.23M |
| Cash outflows from operating activities | 17.85%53.01M | -0.94%184.88M | -1.75%134.08M | -1.03%87.48M | -5.43%44.98M | -4.46%186.63M | -22.11%136.47M | -30.49%88.39M | -35.24%47.56M | -30.22%195.33M |
| Net cash flows from operating activities | -255.99%-10.13M | -8.12%22.41M | -65.25%5.76M | -109.96%-1.04M | -134.97%-2.84M | 41.85%24.39M | 237.91%16.58M | 174.98%10.46M | 230.93%8.14M | 520.21%17.19M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -25.43%354.18M | 48.42%2.06B | 134.12%1.39B | 150.00%1.13B | 850.00%475M | 28.53%1.39B | 2.23%595M | 167.24%450M | 0.00%50M | 252.61%1.08B |
| Cash received from returns on investments | 122.71%3.36M | -0.96%11.07M | 112.61%5.79M | 180.46%4.65M | 104.99%1.51M | 61.38%11.17M | -61.03%2.72M | -55.64%1.66M | -75.59%736.51K | -21.62%6.92M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | -81.22%209.57K | --4.6K | ---- | ---- | 186.34%1.12M | ---- | ---- | ---- | -44.59%389.65K |
| Cash inflows from investing activities | -24.97%357.55M | 47.92%2.07B | 134.02%1.4B | 150.11%1.13B | 839.19%476.51M | 28.80%1.4B | 1.46%597.72M | 162.40%451.66M | -4.30%50.74M | 244.29%1.09B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | ---- | -32.78%7.07M | -69.23%1.5M | -67.72%906.93K | -56.48%599.43K | -48.38%10.52M | -17.37%4.88M | -44.19%2.81M | 43.36%1.38M | -3.89%20.39M |
| Cash paid to acquire investments | -13.69%350M | 30.88%2.24B | 61.37%1.51B | 45.35%1.16B | 523.87%405.52M | 123.60%1.71B | 407.57%938.18M | 396.45%795M | -8.05%65M | -8.40%766.43M |
| Cash outflows from investing activities | -13.82%350M | 30.49%2.25B | 60.70%1.52B | 44.95%1.16B | 511.83%406.12M | 119.15%1.72B | 394.42%943.06M | 383.02%797.81M | -7.36%66.38M | -8.29%786.82M |
| Net cash flows from investing activities | -89.28%7.55M | 45.40%-175.8M | 66.21%-116.68M | 92.27%-26.77M | 550.06%70.39M | -206.65%-321.99M | -186.68%-345.34M | -5,075.98%-346.15M | 16.05%-15.64M | 155.74%301.92M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | --2.63M | --2.63M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other financing activities | ---- | ---- | --65.26K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | ---- | --2.63M | --2.69M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Dividend interest payment | ---- | -17.27%9.69M | -51.28%3.87M | -51.28%3.87M | ---- | 134.20%11.71M | 59.16%7.95M | 58.91%7.95M | --106.33K | --5M |
| Cash payments relating to other financing activities | 31.46%925.39K | -93.63%2.48M | -94.33%2.13M | -93.83%1.49M | -94.20%703.91K | 881.65%38.93M | 1,356.02%37.51M | 1,676.87%24.17M | 1,108.30%12.13M | -86.04%3.97M |
| Cash outflows from financing activities | 31.46%925.39K | -75.97%12.17M | -86.80%6M | -83.30%5.36M | -94.25%703.91K | 464.83%50.64M | 500.63%45.46M | 404.90%32.11M | 1,118.89%12.23M | -68.43%8.97M |
| Net cash flows from financing activities | -31.46%-925.39K | 81.16%-9.54M | 92.72%-3.31M | 83.30%-5.36M | 94.25%-703.91K | -464.83%-50.64M | -500.63%-45.46M | -404.90%-32.11M | -1,118.89%-12.23M | -101.39%-8.97M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -130.97%-154.95K | -317.64%-1.21M | 409.83%847.07K | 75.93%469.8K | 517.64%500.25K | 15.26%556.83K | -106.70%-273.4K | -91.95%267.04K | -46.09%80.99K | 415.57%483.11K |
| Adjustment items effecting cash and cash equivalents | --0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net increase in cash and cash equivalents | -105.43%-3.66M | 52.79%-164.14M | 69.73%-113.38M | 91.10%-32.7M | 442.59%67.35M | -211.93%-347.69M | -197.81%-374.49M | -3,563.05%-367.54M | 23.50%-19.66M | 206.45%310.63M |
| Add:Begin period cash and cash equivalents | -62.75%97.43M | -57.07%261.58M | -57.07%261.58M | -57.07%261.58M | -57.07%261.58M | 104.02%609.27M | 104.02%609.27M | 104.02%609.27M | 103.81%609.27M | 51.38%298.63M |
| End period cash equivalent | -71.49%93.77M | -62.75%97.43M | -36.88%148.2M | -5.32%228.87M | -44.21%328.92M | -57.07%261.58M | -65.55%234.77M | -16.24%241.73M | 115.79%589.61M | 104.02%609.27M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | -- | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm